Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Treasury Shares (2022 - 2025)

Rxo (RXO) has disclosed Treasury Shares for 4 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares fell 2.42% year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Dec 2025, down 2.42%, and an annual FY2025 reading of $1.7 million, down 2.42% over the prior year.
  • Treasury Shares was $1.7 million for Q4 2025 at Rxo, down from $1.7 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.7 million in Q4 2024 and bottomed at $100000.0 in Q4 2023.
  • Average Treasury Shares over 4 years is $1.1 million, with a median of $1.3 million recorded in 2022.
  • The sharpest move saw Treasury Shares crashed 88.85% in 2023, then skyrocketed 1612.38% in 2024.
  • Year by year, Treasury Shares stood at $896631.0 in 2022, then plummeted by 88.85% to $100000.0 in 2023, then surged by 1612.38% to $1.7 million in 2024, then fell by 2.42% to $1.7 million in 2025.
  • Business Quant data shows Treasury Shares for RXO at $1.7 million in Q4 2025, $1.7 million in Q4 2024, and $100000.0 in Q4 2023.